Skip to main content
. 2022 Nov 2;57(Suppl 1):100–416. doi: 10.1038/s41409-022-01798-0
Organ Involvement Baseline; n (%) After cycle 2; n (%)
Skin 3 (100) Severe 2 (66.66) Moderate/1 (33.33) Severe
Mouth 2 (66.66) None/1 (33.33) Mild 3 (100) None
Gastrointestinal 2 (66.66) None/1 (33.33) Mild 3 (100) None
Liver 2 (66.66) None/1 (33.33) Mild 2 (66.66) None/1 (33.33) Mild
Lung 2 (66.66) None/1 (33.33) Mild 3 (100) None
Joint 3 (100) Moderate 2 (66.66) None/1 (33.33) Mild
NIH global severity scale 3 (100) Severe 2 (66.66) Moderate/1 (33.33) Severe